NEA / ΑΡΘΡΑ

The last guidelines on male late-onset hypogonadism (LOH—now more appropriately referred to as functional hypogonadism) from the European Academy of Andrology (EAA) have been published 10 years ago in collaboration with several other international societies. More recently, our understanding of underlying mechanisms of functional hypogonadism as well as of pros and cons of testosterone (T) replacement therapy (TRT) has improved. Comorbidities, obesity and the metabolic syndrome (MetS), amongst other causes (see later), may contribute independently to individual rates and extent of the apparent age-related decline of T observed in middle-aged and elderly men.

Διαβάστε ολόκληρο το άρθρο εδώ.